Product Images Budesonide Inhalation Suspension

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Budesonide Inhalation Suspension NDC 76282-642 by Exelan Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

bb2e8526 80f5 4cee ab3b fb80dfc3241e 01

bb2e8526 80f5 4cee ab3b fb80dfc3241e 01

bb2e8526 80f5 4cee ab3b fb80dfc3241e 02

bb2e8526 80f5 4cee ab3b fb80dfc3241e 02

This text includes information about a medication regimen consisting of taking 0.25 mg of Placebo once a day and 10 mg once a day of an unspecified medication. The text also includes numbered sections but without sufficient context or further information.Usage or meaning could not be determined from the given text.*

bb2e8526 80f5 4cee ab3b fb80dfc3241e 03

bb2e8526 80f5 4cee ab3b fb80dfc3241e 03

bb2e8526 80f5 4cee ab3b fb80dfc3241e 04

bb2e8526 80f5 4cee ab3b fb80dfc3241e 04

bb2e8526 80f5 4cee ab3b fb80dfc3241e 05

bb2e8526 80f5 4cee ab3b fb80dfc3241e 05

bb2e8526 80f5 4cee ab3b fb80dfc3241e 06

bb2e8526 80f5 4cee ab3b fb80dfc3241e 06

bb2e8526 80f5 4cee ab3b fb80dfc3241e 07

bb2e8526 80f5 4cee ab3b fb80dfc3241e 07

bb2e8526 80f5 4cee ab3b fb80dfc3241e 08

bb2e8526 80f5 4cee ab3b fb80dfc3241e 08

bb2e8526 80f5 4cee ab3b fb80dfc3241e 09

bb2e8526 80f5 4cee ab3b fb80dfc3241e 09

This is a description of a medication called Budesonide Inhalation Suspension, which is packaged in a single-dose ampule. It is for inhalation only and contains 0.25 mg of micronized budesonide. The usual dosage is not specified, but instructions indicate that one opened ampule should be used immediately in a nebulizer, and ampules should be stored properly. The text also indicates that the medication should be used as directed by a physician and should be kept out of the reach of children. The lot number and expiration date are provided.*

bb2e8526 80f5 4cee ab3b fb80dfc3241e 10

bb2e8526 80f5 4cee ab3b fb80dfc3241e 10

bb2e8526 80f5 4cee ab3b fb80dfc3241e 11

bb2e8526 80f5 4cee ab3b fb80dfc3241e 11

This is a medication called Budesonide in inhalation suspension form. The foil envelope containing single-dose ampules should be opened and used within two weeks. This medication is meant for inhalation use only and should not be discarded until the last ampule has been used. The provided text unfortunately provides no further details about the use or indications of this medication.*

bb2e8526 80f5 4cee ab3b fb80dfc3241e 12

bb2e8526 80f5 4cee ab3b fb80dfc3241e 12

Budesonide Inhalation Suspension is a medication meant for inhalation purposes only. The text includes dosage-specific information and mentions the product is stored in single-dose Rxonly ampules per pack.*

bb2e8526 80f5 4cee ab3b fb80dfc3241e 13

bb2e8526 80f5 4cee ab3b fb80dfc3241e 13

The text describes a medication called Budesonide in inhalation suspension form. The medication is meant for inhalation only and is contained in single-dose ampules. The medication is provided in a envelope that contains five ampules. The medication has a prescription label and has an expiration date. The text also includes a warning not to discard the foil envelope until the last ampule is taken. The rest of the text is not clear or not readable.*

bb2e8526 80f5 4cee ab3b fb80dfc3241e 14

bb2e8526 80f5 4cee ab3b fb80dfc3241e 14

This is a pharmaceutical product description for Budesonide Inhalation Suspension. The product is intended for inhalation only and contains 1 mg/2 mL of the suspension. It also mentions a store location at 17 Store St.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.